HMC Hosts 4Th Annual Doha-Heidelberg Rare Diseases Conference
(MENAFN- The Peninsula) The Peninsula
Doha: The fourth edition of the successful Doha–Heidelberg research conference on Rare Diseases was recently hosted by Hamad Medical Corporation (HMC) and Heidelberg University Hospital (HUH) at the Itqan Simulation and Clinical Innovation Center in Doha.
The specialised educational conference discussed updates on the diagnosis and management of rare diseases with an in-depth focus on personalized medicine and genetic therapies.
Conference Chair Dr. Saad Al Kaabi, chair of rare disease committee and Chairman of the International Medical Affairs Office at HMC, said that the long relationship with the Heidelberg University Hospital has witnessed many achievements and resulted in numeroud accomplishments over the past two decades.“Our continued strong collaboration with Heidelberg University Hospital has ensured that once again we were able to deliver a high-standard scientific conference. This continuing professional development event was arranged to promote learning, education, and research among healthcare professionals with a keen interest in Rare Diseases; it also highlighted the latest advancements in the diagnosis and management of rare diseases, research advancement and ethical considerations in dealing with rare diseases,” said Dr. Al-Kaabi.
“Our aim is to continue making this an exceptional event for all healthcare professionals interested in rare diseases, and related scientific research in Qatar and the region.”
The conference brought together clinicians, scientists, researchers and other stakeholders from different organizations to exchange knowledge and explore new opportunities for clinical and research collaborations. It was open to anyone from within Qatar's Academic Health System as well as healthcare professionals working in the private sector.
Conference Co-Chair Dr. Reem Al Sulaiman, interim deputy chair of medical genetics department and assistant chair of rare disease committee, said that clinicians from Qatar and Germany had many valuable exchanges in knowledge and experiences that have benefited all patients in both countries in recent years.
“The special collaboration between HMC and Heidelberg University Hospital in the field of newborn screening is a great example that had provided an optimal frame to construct a new innovative research project“Genomic Newborn Screening”, a novel and innovative screening to detect genetic disorders before clinical presentation. This approach is designed to prevent the disease through early diagnosis and treatment,” said Dr. Al Sulaiman.
“The existing infrastructure at HMC and the long-term collaboration with Heidelberg University Hospital will ensure the successful implementation of this ambitious and unique project making HMC a pioneer in this field in the Middle East.”
MENAFN09032023000063011010ID1105736934
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.